logo-loader

Iovance Biotherapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$2.81 billion
Price
22.25 USD
Change
-1.98%
52 weeks high
29.64
52 weeks low
8.32

In brief

IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).